Neuroendokrin daganatok: vizsgálatok itt: Lengyelország
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Gdansk, Katowice, Wroclaw
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Gliwice, Katowice, Krakow, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - No phaseTaking peopleMulticenter Study for External Validation of the TB-NET Score
- Where
- Krakow
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532 - 1/2. fázisNot yet taking people in LengyelországDAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Wroclaw
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Bydgoszcz, Warsaw
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Cracow, Gdansk, Gliwice, Poznan, Warsaw, Warszawa
- Életkor
- 12 év to 100 év
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - 3. fázisNot yet taking people in LengyelországTandem therapy LutaPol/ltraPol ( I 77Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasmas.
- Where
- Cracow, Kielce, Warsaw
- Életkor
- 18 év and over
- People
- 92
- Run by
- Narodowe Centrum Badan Jadrowych
See details and how to join2024-516503-17-01 · EU 2024-516503-17-01 - 3. fázisTaking peopleStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Gdansk, Warsaw, Wilkowice
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 · EU 2024-520050-38-00 - 2. fázisTaking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Lublin, Poznan
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - No phaseNot yet taking people in LengyelországCardioNETPOL National Registry of Carcinoid Heart Disease
- Where
- Warsaw
- Életkor
- 18 év and over
- People
- 120
- Run by
- National Institute of Cardiology, Warsaw, Poland
See details and how to joinNCT07450287 - No phaseNot yet taking people in LengyelországAdvanced Endoscopic Resections for Rectal Neoplasms
- Where
- Krakow
- Életkor
- 18 év and over
- People
- 300
- Run by
- Jagiellonian University
See details and how to joinNCT07410767 - No phaseTaking peopleClinical Application of the J-PET Scanner Prototype
- Where
- Krakow
- Életkor
- 18 év and over
- People
- 25
- Run by
- Jagiellonian University
See details and how to joinNCT06242119